GPA
Garrison Point Advisors’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
10,569
-470
| -4% | -$59.5K | 0.61% | 46 |
|
|
2025
Q1 | $1.41M | Buy |
11,039
+621
| +6% | +$79.4K | 0.68% | 41 |
|
|
2024
Q4 | $1.38M | Sell |
10,418
-92
| -0.9% | -$12.2K | 0.65% | 42 |
|
|
2024
Q3 | $1.53M | Buy |
10,510
+68
| +0.7% | +$9.9K | 0.95% | 32 |
|
|
2024
Q2 | $1.43M | Buy |
10,442
+158
| +2% | +$21.7K | 0.95% | 29 |
|
|
2024
Q1 | $1.41M | Buy |
10,284
+217
| +2% | +$29.8K | 0.91% | 30 |
|
|
2023
Q4 | $1.37M | Sell |
10,067
-35
| -0.3% | -$4.76K | 0.96% | 31 |
|
|
2023
Q3 | $1.24M | Sell |
10,102
-82
| -0.8% | -$10K | 0.96% | 30 |
|
|
2023
Q2 | $1.29M | Sell |
10,184
-50
| -0.5% | -$6.35K | 0.93% | 31 |
|
|
2023
Q1 | $1.32M | Buy |
10,234
+6
| +0.1% | +$775 | 0.99% | 27 |
|
|
2022
Q4 | $1.34M | Hold |
10,228
| – | – | 1.1% | 27 |
|
|
2022
Q3 | $1.2M | Buy |
10,228
+30
| +0.3% | +$3.51K | 1.07% | 29 |
|
|
2022
Q2 | $1.2M | Buy |
10,198
+48
| +0.5% | +$5.65K | 1% | 34 |
|
|
2022
Q1 | $1.32M | Buy |
10,150
+217
| +2% | +$28.3K | 0.93% | 32 |
|
|
2021
Q4 | $1.52M | Buy |
9,933
+257
| +3% | +$39.2K | 1.01% | 28 |
|
|
2021
Q3 | $1.56M | Sell |
9,676
-70
| -0.7% | -$11.3K | 1.14% | 26 |
|
|
2021
Q2 | $1.6M | Sell |
9,746
-10
| -0.1% | -$1.64K | 1.15% | 26 |
|
|
2021
Q1 | $1.47M | Sell |
9,756
-20
| -0.2% | -$3.01K | 1.14% | 27 |
|
|
2020
Q4 | $1.48M | Hold |
9,776
| – | – | 1.19% | 24 |
|
|
2020
Q3 | $1.32M | Sell |
9,776
-10
| -0.1% | -$1.35K | 1.2% | 25 |
|
|
2020
Q2 | $1.34M | Sell |
9,786
-515
| -5% | -$70.4K | 1.32% | 23 |
|
|
2020
Q1 | $1.11M | Sell |
10,301
-315
| -3% | -$33.9K | 1.36% | 27 |
|
|
2019
Q4 | $1.28M | Sell |
10,616
-60
| -0.6% | -$7.23K | 1.17% | 32 |
|
|
2019
Q3 | $1.06M | Buy |
10,676
+200
| +2% | +$19.9K | 1.05% | 34 |
|
|
2019
Q2 | $1.14M | Buy |
10,476
+345
| +3% | +$37.6K | 1.15% | 32 |
|
|
2019
Q1 | $1.13M | Buy |
10,131
+435
| +4% | +$48.6K | 1.18% | 30 |
|
|
2018
Q4 | $935K | Buy |
+9,696
| New | +$935K | 1.15% | 31 |
|